Jump to content

Moprolol

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Moprolol
Names
IUPAC name
1-(2-Methoxyphenoxy)-3-(propan-2-ylamino)propan-2-ol
Other names
(±)-Moprolol
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.024.777 Edit this at Wikidata
EC Number
  • 248-195-3
MeSH C009976
UNII
  • InChI=1S/C13H21NO3/c1-10(2)14-8-11(15)9-17-13-7-5-4-6-12(13)16-3/h4-7,10-11,14-15H,8-9H2,1-3H3
    Key: LFTFGCDECFPSQD-UHFFFAOYSA-N
  • InChI=1/C13H21NO3/c1-10(2)14-8-11(15)9-17-13-7-5-4-6-12(13)16-3/h4-7,10-11,14-15H,8-9H2,1-3H3
    Key: LFTFGCDECFPSQD-UHFFFAOYAX
  • CC(C)NCC(COC1=CC=CC=C1OC)O
Properties
C13H21NO3
Molar mass 239.315 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Moprolol is a beta-adrenergic antagonist, or beta blocker. It is typically prescribed to treat hypertension, high blood pressure, angina pectoris, arrhythmias, anxiety, and glaucoma.[1]

Moprolol is currently off the market, most likely due to the manufacturer being in violation of US good manufacturing practices.[1]

See also

References

  1. ^ a b "MOPROLOL". National Center for Advancing Translational Sciences. Retrieved 11 October 2024.